However, tumours upregulate PD-L1/2 in response to T-cell-derived IFN-γ in order to escape immunosurveillance and maintain a general anti-inflammatory milieu; a phenomenon known as “adaptive immune resistance” [69]. This evidence concerns the gene IFNG and neoplasm.